The aim of this study was to assess the relationship between sex and clinical outcomes and treatment-related complications in patients with ST-elevation or non-ST-elevation acute coronary syndromes ( ACS ) randomized to treatment with ticagrelor or clopidogrel in the PLATelet inhibition and patient Outcomes ( PLATO ) trial .